In Vitro–In Vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development-Reference-Cited by-同舟云学术

In Vitro–In Vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development

Published:2018-01 Issue:1 Volume:107 Page:453-465
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Warnken Zachary,Puppolo Michael,Hughey Justin,Duarte Iris,Jansen-Varnum Susan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations;U.S. Food and Drug Administration,1997

2. In Vivo Evaluation of Dosage Forms< 1088>. United States Pharmacopeia and National Formulary USP 32–NF 27,2008

3. Development of in vitro–in vivo correlation for amorphous solid dispersion immediate-release suvorexant tablets and application to clinically relevant dissolution specifications and in-process controls;Kesisoglou;J Pharm Sci,2015

4. In vitro–in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers;Balan;J Pharm Sci,2001

5. In vitro–in vivo correlations: tricks and traps;Cardot;AAPS J,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics;European Journal of Pharmaceutical Sciences;2023-08

2. Evaluation of Extended-release of Piroxicam-loaded Pectin-zein Hydrogel Microspheres: In vitro, Ex vivo, and In vivo Studies;Current Drug Delivery;2022-12

3. Modification of small dissolution chamber system for long-acting periodontal drug product evaluation;International Journal of Pharmaceutics;2022-04

4. Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review;European Journal of Pharmaceutical Sciences;2022-03

5. Advances in nanocrystals as drug delivery systems;Nanoparticle Therapeutics;2022